| Date Filed | Type | Description |
| 09/27/2023 |
3
| DEVILLIERS TANIA (INT PRIN ACCTG OFC) has filed a Form 3 on BIO-RAD LABORATORIES, INC. |
| 08/25/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/23/2023 |
4
| ERNST TIMOTHY S (EVP, General Counsel & Sec) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Sold 300 shares
@ $384.69, valued at
$115.4k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
8-K
| Quarterly results |
| 06/16/2023 |
4
| Crowley Michael (EVP, GBL Commercial Operations) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Sold 500 shares
@ $379.39, valued at
$189.7k
|
|
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| RAMALINGAM AJIT (SVP, Chief Accounting Officer) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Sold 17 shares
@ $368.49, valued at
$6.4k
Sold 181 shares
@ $368.28, valued at
$66.7k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
SD
| Form SD - Specialized disclosure report: |
| 05/05/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/04/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
4
| Last Andrew J. (EVP, COO) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Paid exercise price by delivering 346 shares
@ $450.79, valued at
$156k
Exercised 1,000 restricted stock units
@ $0 |
|
| 05/01/2023 |
4
| RAMALINGAM AJIT (SVP, Chief Accounting Officer) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Paid exercise price by delivering 96 shares
@ $450.79, valued at
$43.3k
Exercised 277 restricted stock units
@ $0 |
|
| 03/29/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 03/29/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/08/2023 |
4
| ERNST TIMOTHY S (EVP, General Counsel & Sec) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Sold 1,000 shares
@ $486.08, valued at
$486.1k
Sold 746 shares
@ $486.89, valued at
$363.2k
Exercised 850 options to buy
@ $159.32, valued at
$135.4k
Exercised 150 options to buy
@ $215.98, valued at
$32.4k
|
|
| 02/23/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2023 |
4
| RAMALINGAM AJIT (SVP, Chief Accounting Officer) has filed a Form 4 on BIO-RAD LABORATORIES, INC.|
Txns:
| Granted 644 restricted stock units
@ $0 |
|
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 1% stake in BIO-RAD LABORATORIES INC |
| 01/10/2023 |
8-K
| Investor presentation |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
8-K
| Regulation FD Disclosure Interactive Data |
| 10/28/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/27/2022 |
8-K
| Quarterly results |
|